These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 27118057)
1. Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA Chan PH; Huang D; Lau CP; Chan EW; Wong IC; Lip GY; Tse HF; Siu CW Can J Cardiol; 2016 Oct; 32(10):1247.e15-1247.e21. PubMed ID: 27118057 [TBL] [Abstract][Full Text] [Related]
2. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control. Ho CW; Ho MH; Chan PH; Hai JJ; Cheung E; Yeung CY; Lau KK; Chan KH; Lau CP; Lip GY; Leung GK; Tse HF; Siu CW Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148 [TBL] [Abstract][Full Text] [Related]
3. Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial Fibrillation. Chan PH; Li WH; Hai JJ; Chan EW; Wong IC; Tse HF; Lip GY; Siu CW Can J Cardiol; 2016 Oct; 32(10):1247.e23-1247.e28. PubMed ID: 26927855 [TBL] [Abstract][Full Text] [Related]
4. Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation. Chan PH; Huang D; Hai JJ; Li WH; Yin LX; Chan EW; Wong IC; Lau CP; Chiang CE; Zhu J; Tse HF; Siu CW Heart Rhythm; 2016 Feb; 13(2):366-73. PubMed ID: 26392326 [TBL] [Abstract][Full Text] [Related]
5. Comparison of warfarin, rivaroxaban, and dabigatran for effectiveness and safety in atrial fibrillation patients with different CHA2DS2-VASc scores: a retrospective cohort study. Zhao Y; Ren H; Xu S BMC Cardiovasc Disord; 2024 Jul; 24(1):361. PubMed ID: 39014359 [TBL] [Abstract][Full Text] [Related]
6. Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage. Chao TF; Liu CJ; Liao JN; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chen TJ; Lip GY; Chen SA Circulation; 2016 Apr; 133(16):1540-7. PubMed ID: 26969761 [TBL] [Abstract][Full Text] [Related]
7. Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong. Siu CW; Lip GY; Lam KF; Tse HF Heart Rhythm; 2014 Aug; 11(8):1401-8. PubMed ID: 24747420 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of the CHA Jaakkola S; Kiviniemi TO; Nuotio I; Hartikainen J; Mustonen P; Palomäki A; Jaakkola J; Ylitalo A; Hartikainen P; Airaksinen KEJ Am J Cardiol; 2018 May; 121(10):1182-1186. PubMed ID: 29526276 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project. Li WH; Huang D; Chiang CE; Lau CP; Tse HF; Chan EW; Wong ICK; Lip GYH; Chan PH; Siu CW Clin Cardiol; 2017 Apr; 40(4):222-229. PubMed ID: 27893153 [TBL] [Abstract][Full Text] [Related]
10. Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study. Chao TF; Lip GY; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA Stroke; 2016 Oct; 47(10):2462-9. PubMed ID: 27625386 [TBL] [Abstract][Full Text] [Related]
11. The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation. Vinding NE; Bonde AN; Rørth R; Lamberts M; Olesen JB; Gislason GH; Torp-Pedersen C; Køber L; Fosbøl EL Europace; 2019 Apr; 21(4):572-580. PubMed ID: 30508073 [TBL] [Abstract][Full Text] [Related]
12. Net clinical benefit of warfarin therapy in elderly Chinese patients with atrial fibrillation. Siu CW; Tse HF Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):300-6. PubMed ID: 24610776 [TBL] [Abstract][Full Text] [Related]
13. A comparison of dabigatran and warfarin for stroke prevention in elderly Asian population with nonvalvular atrial fibrillation: An audit of current practice in Malaysia. Yap SH; Ng YP; Roslan A; Kolanthaivelu J; Koh KW; P'ng HS; Boo YL; Hoo FK; Yap LB Med J Malaysia; 2017 Dec; 72(6):360-364. PubMed ID: 29308774 [TBL] [Abstract][Full Text] [Related]
14. Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis. Chan PH; Huang D; Yip PS; Hai J; Tse HF; Chan TM; Lip GY; Lo WK; Siu CW Europace; 2016 May; 18(5):665-71. PubMed ID: 26504109 [TBL] [Abstract][Full Text] [Related]
15. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study. Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342 [TBL] [Abstract][Full Text] [Related]
16. Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Jackson LR; Kim S; Shrader P; Blanco R; Thomas L; Ezekowitz MD; Ansell J; Fonarow GC; Gersh BJ; Go AS; Kowey PR; Mahaffey KW; Hylek EM; Peterson ED; Piccini JP J Thromb Thrombolysis; 2018 Nov; 46(4):435-439. PubMed ID: 30051164 [TBL] [Abstract][Full Text] [Related]
17. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study. Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231 [TBL] [Abstract][Full Text] [Related]
18. Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry. Watanabe E; Yamamoto M; Kodama I; Inoue H; Atarashi H; Okumura K; Yamashita T; Lip GY; Kodani E; Okuyama Y; Chishaki A; Kiyono K; Origasa H; Int J Cardiol; 2016 Jun; 212():311-7. PubMed ID: 27057949 [TBL] [Abstract][Full Text] [Related]
19. Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis. Romanelli RJ; Nolting L; Dolginsky M; Kym E; Orrico KB Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):126-34. PubMed ID: 26812933 [TBL] [Abstract][Full Text] [Related]
20. Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation With Low Stroke Risk. Fong KY; Chan YH; Yeo C; Lip GYH; Tan VH Am J Cardiol; 2023 Oct; 204():366-376. PubMed ID: 37573616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]